Syndax Pharmaceuticals develops and sells cancer medicines, including Revuforj for certain acute leukemias. It last closed at $9.20 on Nov 17, up 0.77% on the day. The average 12-month price target from 2 analysts is $34.50 (+275.0% from the last close), with a high of $36.00 and a low of $33.00. In the past 30 days there were 2 dark pool prints totaling $1.5M, the largest $1.1M.
Only 2 firms rated SNDX in the past 90 days, not enough for a consensus
Average 12-month target
$34.50
▲ 275.0% upside
Based on 2 analysts who set a price target on SNDX in the past 90 days. The average target is $34.50, with a high of $36.00 and a low of $33.00, compared with the last close of $9.20.
Low $33.00Avg $34.50High $36.00
Blue marker: last close $9.20
Highest target$36.00
Average target$34.50
Lowest target$33.00
Latest rating changes
HC Wainwright & Co.Target lowered
Nov 3Buy$38 → $36
HC Wainwright & Co.Reiterated
Oct 13Buy$38
UBSMaintained
Aug 21Buy$33
JP MorganMaintained
Aug 11Buy$40
HC Wainwright & Co.Target lowered
Aug 5Buy$40 → $38
Date
Firm
Action
Rating
Price target
Nov 3
HC Wainwright & Co.
Target lowered
Buy
$38 → $36
Oct 13
HC Wainwright & Co.
Reiterated
Buy
$38
Aug 21
UBS
Maintained
Buy
$33
Aug 11
JP Morgan
Maintained
Buy
$40
Aug 5
HC Wainwright & Co.
Target lowered
Buy
$40 → $38
Loading…
Technical Analysis
SNDX · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 26% below its 20 day and 61% below its 50 day average. It is 113% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 26), oversold. The nearest support is the swing low (Nov 9) at $9.15, and the nearest resistance the Pivot at $9.24.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 9.2%/day
Key levels
$25.5952 week high+178.2%
$19.61200 day average+113.2%
$17.87100 day average+94.2%
$14.8350 day average+61.2%
$11.5920 day average+26.0%
$9.93Swing high (Nov 12)+7.9%
$9.45Pivot R1+2.7%
$9.24Pivot+0.4%
$9.20Last close
$9.15Swing low (Nov 9)−0.5%
$9.0352 week low−1.8%
$8.99Pivot S1−2.3%
Indicators
RSI (14)
25.81
Oversold below 30
Oversold
MACD
-1.72
Below its signal line
Bearish
Stochastic
3.4
Near the bottom of its range
Oversold
ADX (14)
48.2
Strong downtrend
Williams %R
-97.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-82.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−35.6%
Change over 10 sessions
Bearish
ATR (14)
$0.85
Typical daily range, 9.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 22.7%/day
Key levels
$25.5952 week high+178.2%
$19.61200 day average+113.2%
$17.87100 day average+94.2%
$14.8350 day average+61.2%
$11.5920 day average+26.0%
$9.93Swing high (Nov 12)+7.9%
$9.45Pivot R1+2.7%
$9.24Pivot+0.4%
$9.20Last close
$9.15Swing low (Nov 9)−0.5%
$9.0352 week low−1.8%
$8.99Pivot S1−2.3%
Indicators
RSI (14)
25.74
Oversold below 30
Oversold
MACD
-2.64
Below its signal line
Bearish
Stochastic
2.3
Near the bottom of its range
Oversold
ADX (14)
26.0
Trending down
Williams %R
-98.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-162.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−49.4%
Change over 10 sessions
Bearish
ATR (14)
$2.09
Typical daily range, 22.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for SNDX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SNDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow SNDX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How SNDX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SNDX is in one of them and how their past SNDX trades turned out.
Syndax Pharmaceuticals is a biopharmaceutical company based in New York that develops and sells cancer treatments. Its two approved medicines are Revuforj, a pill for certain acute leukemias, and Niktimvo, used to treat chronic graft versus host disease. Syndax leads sales of Revuforj in the United States and works with partner Incyte on Niktimvo. Its customers are cancer patients and the doctors who treat them.